Clinical Trial Update: STROKESTOP III - Optimized Method for Atrial Fibrillation Screening [NA]

View source ↗

Summary

STROKESTOP III is a clinical trial evaluating an optimized method for screening atrial fibrillation and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Danderyd Hospital | Conditions: Atrial Fibrillation, Atrial Fibrillation New Onset | NA | Status: RECRUITING